Emergency medicine journal : EMJ
-
Randomized Controlled Trial Clinical Trial
A randomised trial to investigate the efficacy of magnesium sulphate for refractory ventricular fibrillation.
Ventricular fibrillation (VF) remains the most salvageable rhythm in patients suffering a cardiopulmonary arrest (CA). However, outcome remains poor if there is no response to initial defibrillation. Some evidence suggests that intravenous magnesium may prove to be an effective antiarrhythmic agent in such circumstances. ⋯ Intravenous magnesium given early in patients suffering CA with refractory or recurrent VF did not significantly improve the proportion with a ROSC or who were discharged from hospital alive.